Market Place
Sourcing Support
All News #Library
Biotech
Oxford Biotherapeutics Collaborates With GSK On Cancer Antibody
10 Dec 2025 //
PHARMIWEB
Oxford BioTherapeutics Advances Third Oncology Drug
03 Jul 2025 //
GLOBENEWSWIRE
Roche doubles down on ADCs in $1B biobucks pact with Oxford Bio
19 Mar 2025 //
FIERCE BIOTECH
Boehringer Ingelheim Acquires Fourth Cancer Antibody License
09 Jan 2025 //
GLOBENEWSWIRE
Oxford BioTherapeutics to Present at World ADC Conference 2024
31 Oct 2024 //
GLOBENEWSWIRE
Oxford Bio Announces First Patient Dosed with OBT076 in Phase 1b Trial
18 Jan 2024 //
GLOBENEWSWIRE
Oxford Announces Partner BI Received FDA Fast Track Designation for BI 764532
29 Nov 2023 //
GLOBENEWSWIRE
Boehringer Ingelheim Dosed First Patient in Phase 2 Trial with BI 764532
24 Oct 2023 //
GLOBENEWSWIRE
Oxford Relocates UK Headquarters to Strategic and Cutting-Edge R&D Location
11 Oct 2023 //
GLOBENEWSWIRE
Oxford Announces Partner BI Received FDA Fast Track Designation for BI 764532
02 Oct 2023 //
GLOBENEWSWIRE
Oxford and Boehringer Agree on 2 Year Extension to Multi-Year Collaboration
25 May 2023 //
GLOBENEWSWIRE
Oxford to Announce New Fully Integrated ADC Engine at World ADC Conference 2023
09 Mar 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.